As of Feb 17
| -0.30 / -0.83%|
The 23 analysts offering 12-month price forecasts for Merck KGaA have a median target of 38.83, with a high estimate of 44.13 and a low estimate of 32.51. The median estimate represents a +8.32% increase from the last price of 35.85.
The current consensus among 23 polled investment analysts is to Buy stock in Merck KGaA. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.